GlaxoSmithKline's Shingrix Approved in the U.S. for Prevention of Shingles in Adults Aged 50 and … Post author:Sam Post published:October 22, 2017 Post category:BioPharma Shingrix is a non-live, recombinant subunit vaccine given intramuscularly in two doses. Source: BioSpace You Might Also Like FDA Stuns Celgene With Refusal to File Letter for MS Treatment Ozanimod February 27, 2018 Agilent Joins With To Help Advance Scientific Discovery September 18, 2017 Capital Increase In Bavarian Nordic As A Result Of Employee Warrant Exercise May 17, 2017
